Glaukos Corporation

Healthcare · Medical Devices · United States

Last price 237.6 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.06B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and ...